Completed PHASE4 INTERVENTIONAL 2-arm NCT01269827

Pentoxifylline and Systemic Inflammation in Hemodialysis Patients

Randomized, Double-Blinded, Controlled Clinical Trial of the Effect Pentoxifylline vs Placebo on the Serum Concentrations of TNF-a, IL-6 and CRP of Patients in Hemodialysis

Sponsor: Coordinación de Investigación en Salud, Mexico

Conditions End-stage Renal Disease Hemodialysis Inflammation

Interventions Pentoxifylline starch tablets

Updated 5 times since 2017 Last updated: Dec 18, 2018 Started: Jan 31, 2006 Primary completion: May 31, 2008 Completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01269827, this PHASE4 trial focuses on End-stage Renal Disease and Hemodialysis and remains completed. Sponsored by Coordinación de Investigación en Salud, Mexico, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2019 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jan 2019 [monthly]

Completed PHASE4

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Coordinación de Investigación en Salud, Mexico

Data source: Coordinación de Investigación en Salud, Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guadalajara, Mexico